N
GRTX

Nuveen’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Nuveen’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,027
Closed -$124K – 3572
2021
Q1 		$124K Hold
14,027
– – ﹤0.01% 3272
2020
Q4 		$143K Hold
14,027
– – ﹤0.01% 3226
2020
Q3 		$127K Hold
14,027
– – ﹤0.01% 3198
2020
Q2 		$100K Buy
+14,027
New +$149K ﹤0.01% 3162

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen's GRTX Position: Q2 2021 in Review

Nuveen sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 14,027 shares — an estimated $124K sold.

Nuveen first reported a position in GRTX in Q2 2020 and held it in 4 quarters. The position peaked at $143K in Q4 2020. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

  • Nuveen reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 14,027 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $124K.
  • Nuveen first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Nuveen's Galera Therapeutics, Inc. Common Stock position peaked at $143K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.